![Futures Emas lebih rendah semasa sesi A.S.](https://i-invdn-com.investing.com/news/99c9e7171f1ff29af32c5ceb826611ca_S.jpg)
Daftar untuk membuat makluman bagi Instrumen,
Acara Ekonomi dan kandungan berdasarkan penulis yang diikuti
Daftar Percuma Sudah mempunyai akaun? Daftar Masuk
Sila cuba carian lain
Cari Dana
Negara Disenaraikan:
Penerbit:
Penarafan Morningstar:
Penarafan Risiko:
Kelas Aset:
Kategori:
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
Danske Invest Bioteknologi | 0P0000. | 187.170 | +0.01% | 546.21M | 14/02 |
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
Polar Capital Biotechnology Fund S Income | 0P0000. | 47.770 | -0.23% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund I Income | 0P0000. | 48.390 | +0.35% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund R Income | 0P0000. | 46.050 | +0.37% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund S Income | 0P0000. | 49.850 | +0.36% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund I Income | 0P0000. | 46.380 | -0.22% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund R Income | 0P0000. | 44.130 | -0.23% | 1.96B | 13/02 | ||
Arctic Aurora Biotech Select A SEK Acc | 0P0001. | 1,057.810 | -0.55% | 50.56M | 13/02 |
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
I.B.I Biotechnology | 0P0000. | 175.550 | +0.87% | 16.64M | 12/02 |
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
DWS Biotech LC | 0P0000. | 280.920 | +0.14% | 333.91M | 14/02 | ||
Allianz Biotechnologie A EUR | 0P0000. | 209.970 | +0.55% | 259.36M | 14/02 |
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
Pictet Biotech Z USD | 0P0000. | 1,260.930 | +0.74% | 1.38B | 14/02 | ||
Franklin Biotechnology Discovery Fund N(acc)USD | 0P0000. | 32.750 | +0.09% | 97.09M | 14/02 | ||
Pictet Biotech P EUR | 0P0000. | 871.060 | -0.28% | 1.38B | 14/02 | ||
Pictet Biotech R EUR | 0P0000. | 742.460 | -0.28% | 1.38B | 14/02 | ||
Pictet Biotech I EUR | 0P0000. | 1,056.670 | -0.28% | 1.38B | 14/02 | ||
Candriam Equities L Biotechnology Class C USD Cap | 0P0000. | 865.730 | +1.14% | 1.35B | 13/02 | ||
Candriam Equities L Biotechnology Class I USD Cap | 0P0000. | 5,806.340 | +1.14% | 1.35B | 13/02 | ||
Candriam Equities L Biotechnology Class N USD Cap | 0P0000. | 615.080 | +1.14% | 1.35B | 13/02 | ||
Candriam Equities L Biotechnology Class R USD Cap | 0P0001. | 276.750 | +1.14% | 1.35B | 13/02 | ||
Pictet Biotech I USD | 0P0000. | 1,109.450 | +0.73% | 1.38B | 14/02 | ||
Pictet Biotech R USD | 0P0000. | 780.030 | +0.73% | 1.38B | 14/02 | ||
Pictet Biotech P dy USD | 0P0000. | 914.660 | +0.73% | 1.38B | 14/02 | ||
Pictet Biotech PUSD | 0P0000. | 915.000 | +0.73% | 1.38B | 14/02 | ||
Candriam Equities L Biotechnology Class C EUR Cap | 0P0001. | 234.890 | +0.56% | 1.35B | 13/02 | ||
Pictet Biotech P dy GBP | 0P0000. | 724.480 | -0.40% | 1.38B | 14/02 | ||
Pictet Biotech I dy GBP | 0P0000. | 879.290 | -0.40% | 1.38B | 14/02 | ||
Candriam Equities L Biotechnology Class R GBP Cap | 0P0001. | 375.040 | +0.41% | 1.35B | 13/02 | ||
FCP MEDICAL BioHealth Trends I | 0P0000. | 895.240 | -0.07% | 695.16M | 14/02 | ||
FCP MEDICAL BioHealth-Trends EUR | 0P0000. | 757.800 | -0.07% | 695.16M | 14/02 | ||
Janus Henderson Horizon Biotechnology A2 USD Acc | 0P0001. | 25.190 | +1.00% | 123.64M | 14/02 |
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
Franklin Biotechnology Discovery Fund A(acc)USD | 0P0000. | 39.780 | +0.10% | 1.05B | 14/02 |
Nama | Simbol | Akhir | Prbhn. % | Jumlah Aset | Masa | ||
---|---|---|---|---|---|---|---|
Polar Capital Biotechnology Fund I Income | 0P0000. | 38.640 | -0.36% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund R Income | 0P0000. | 36.770 | -0.35% | 1.96B | 13/02 | ||
Polar Capital Biotechnology Fund S Income | 0P0000. | 39.800 | -0.38% | 1.96B | 13/02 | ||
AXA Framlington Biotech Fund GBP Z Acc | 0P0000. | 5.276 | 0.00% | 315.94M | 14/02 |